Effect of Preoxygenation Position and Examination Position on Hypoxemia During Painless Gastrointestinal Endoscopy
24 juni 2026 uppdaterad av: General Hospital of Ningxia Medical University
Effect of Preoxygenation Position and Examination Position on Hypoxemia During Painless Gastrointestinal Endoscopy: A 2×2 Factorial Randomized Controlled Trial
To investigate the independent effects and interaction of pre-oxygenation position (left lateral vs left lateral with 30° head-up tilt) and examination position (left lateral vs left lateral with 30° head-up tilt) on hypoxemia during painless gastroscopy and colonoscopy using a 2×2 factorial design.
Studieöversikt
Status
Har inte rekryterat ännu
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Painless gastroscopy and colonoscopy represent core minimally invasive techniques for colorectal cancer screening and the diagnosis and treatment of gastrointestinal diseases. By utilizing intravenous sedation to ensure a pain-free experience, these procedures are widely adopted in clinical practice. However, perioperative hypoxemia remains the most common and critical safety complication during sedation for endoscopy. It is primarily caused by anesthesia-induced respiratory depression, tongue base collapse, airway obstruction, diaphragmatic compression, and restricted thoracic movement, with significantly elevated risks observed in obese, elderly, snoring, and short-necked patients.
Hypoxemia may trigger bradycardia, arrhythmias, myocardial ischemia, and cerebral hypoxia. In severe cases, it can lead to apnea, laryngospasm, and forced termination of the procedure, making it a key indicator in endoscopic anesthesia quality control.
Pre-oxygenation is a fundamental measure to increase functional residual capacity (FRC) and prolong the safe apneic time prior to induction, thereby preventing hypoxemia. The examination position directly determines airway patency, mandibular relaxation, diaphragmatic position, and thoracic compliance throughout the procedure. Both are critical, controllable factors regulating perioperative oxygenation. Studies have confirmed that the left lateral position reduces the incidence of hypoxemia, while the left lateral position with 30° head elevation effectively relaxes the mandible, alleviates tongue base collapse, reduces abdominal organ pressure on the diaphragm, and improves ventilation and oxygenation by increasing FRC.
Current research largely focuses on either the pre-oxygenation position or the examination position in isolation, presenting notable limitations: first, the interaction between these two positions has not been evaluated, leaving the synergistic or antagonistic effects of combined interventions unclear; second, there is a lack of efficient validation using a factorial design, which is necessary to simultaneously analyze the main effects and interactions of both independent variables.
Addressing these clinical challenges and research gaps, this study employs a 2×2 factorial randomized controlled design. With pre-oxygenation position and examination position serving as the two intervention factors, the study aims to explore the individual and combined effects of both factors on perioperative hypoxemia. The objective is to identify the optimal positional combination, establish standardized and generalizable positioning protocols for painless endoscopy, accurately reduce the incidence of hypoxemia, enhance the precision of anesthesia management, and provide high-level evidence to guide clinical practice.
Studietyp
Interventionell
Inskrivning (Beräknad)
208
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: xiaoyong wei, Master's degree
- Telefonnummer: 86-951-674-3252
- E-post: weixy9912@126.com
Studieorter
-
-
Ningxia
-
Yinchuan, Ningxia, Kina, 750001
- General Hospital of Ningxia Medical University
-
Kontakt:
- xiaoyong wei, Master's degree
- Telefonnummer: 86-951-674-3252
- E-post: weixy9912@126.cm
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- Aged 18 to 75 years, regardless of gender
- Body mass index (BMI): 18.5 - 35 kg/m²
- ASA physical status class I, II or III
- Scheduled for painless gastroscopy, painless colonoscopy, or combined painless gastroenteroscopy
- Able to understand the study procedure and provide written informed consent
Exclusion Criteria:
- Severe cardiopulmonary diseases, including severe COPD, heart failure, severe arrhythmia and pulmonary hypertension
- Difficult airway identified before anesthesia
- Severe obstructive sleep apnea (OSA)
- Spinal or thoracic deformity
- Preoperative baseline hypoxemia
- Known allergy to any anesthetic drugs used in this study
- Pregnant females
- Unable to cooperate with required intraoperative body position
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Group A1B1 (traditional conventional group)
Pre-oxygenated left lateral position + examination in left lateral position
|
An angle measuring device is placed beside the head of the examination bed to enable precise adjustment of the head position.
Pre-oxygenation phase: Administer pure oxygen via a standardized mask with tight fit, at a flow rate of 6 L/min; instruct the patient to take deep breaths while receiving continuous oxygen for 3 minutes, maintaining the same body position throughout.
If the position is altered during this phase, discontinue the procedure.
Left lateral pre-oxygenation: The patient assumes a left lateral position on a horizontal bed surface with the head elevated at 0°, supported by pillows to maintain a neutral spine position and avoid excessive neck extension or flexion.
Andra namn:
Examination Phase: From the initiation of anesthesia and endoscope insertion until completion of the procedure, the patient's position and head-of-bed angle must remain fixed throughout; any adjustments are prohibited during this phase.
If the position is altered midway through the examination, the patient will be excluded from the study.
Left lateral position examination: The patient assumes a 90-degree left lateral position on a horizontal bed surface with the head of the bed elevated to 0°, supported by pillows to maintain a neutral spinal alignment, avoiding excessive neck extension or flexion.
Andra namn:
|
|
Experimentell: Group A1B2 (improved examination group)
Left lateral position with pre-oxygenation + left head elevated 30° during examination
|
An angle measuring device is placed beside the head of the examination bed to enable precise adjustment of the head position.
Pre-oxygenation phase: Administer pure oxygen via a standardized mask with tight fit, at a flow rate of 6 L/min; instruct the patient to take deep breaths while receiving continuous oxygen for 3 minutes, maintaining the same body position throughout.
If the position is altered during this phase, discontinue the procedure.
Left lateral pre-oxygenation: The patient assumes a left lateral position on a horizontal bed surface with the head elevated at 0°, supported by pillows to maintain a neutral spine position and avoid excessive neck extension or flexion.
Andra namn:
Examination Phase: From the initiation of anesthesia and endoscope insertion until completion of the procedure, the patient's position and head-of-bed angle must remain fixed throughout; any adjustments are prohibited during this phase.
If the position is altered midway through the examination, the patient will be excluded from the study.
Left lateral decubitus examination: The patient assumes a left lateral position on a horizontal bed surface with the head elevated at 30°, supported by a pillow to maintain a neutral spinal alignment, avoiding excessive neck extension or flexion.
Andra namn:
|
|
Experimentell: Group A2B1 (pre-oxygenation improvement group)
Left-sided head position at 30°, pre-oxygenated air administration + examination in left lateral decubitus position
|
Examination Phase: From the initiation of anesthesia and endoscope insertion until completion of the procedure, the patient's position and head-of-bed angle must remain fixed throughout; any adjustments are prohibited during this phase.
If the position is altered midway through the examination, the patient will be excluded from the study.
Left lateral position examination: The patient assumes a 90-degree left lateral position on a horizontal bed surface with the head of the bed elevated to 0°, supported by pillows to maintain a neutral spinal alignment, avoiding excessive neck extension or flexion.
Andra namn:
An angle measuring device is placed beside the head of the examination bed to allow precise adjustment of the head position.
Pre-oxygenation phase: The patient receives pure oxygen via a standardized mask with tight fit, at a flow rate of 6 L/min; they are instructed to take deep breaths while receiving continuous oxygen for 3 minutes, maintaining the same body position throughout.
If the position is altered during this phase, the procedure is discontinued.
Left-sided head elevation (30°): During pre-oxygenation, the patient lies in a left lateral position on a horizontal bed surface with the head elevated by 30°, supported by pillows to maintain a neutral spinal alignment and prevent excessive neck extension or flexion.
Andra namn:
|
|
Experimentell: Group A2B2 (double-position improvement group)
Left-sided head height at 30 weeks: pre-oxygenated condition + left-sided head height at 30 weeks examination
|
Examination Phase: From the initiation of anesthesia and endoscope insertion until completion of the procedure, the patient's position and head-of-bed angle must remain fixed throughout; any adjustments are prohibited during this phase.
If the position is altered midway through the examination, the patient will be excluded from the study.
Left lateral decubitus examination: The patient assumes a left lateral position on a horizontal bed surface with the head elevated at 30°, supported by a pillow to maintain a neutral spinal alignment, avoiding excessive neck extension or flexion.
Andra namn:
An angle measuring device is placed beside the head of the examination bed to allow precise adjustment of the head position.
Pre-oxygenation phase: The patient receives pure oxygen via a standardized mask with tight fit, at a flow rate of 6 L/min; they are instructed to take deep breaths while receiving continuous oxygen for 3 minutes, maintaining the same body position throughout.
If the position is altered during this phase, the procedure is discontinued.
Left-sided head elevation (30°): During pre-oxygenation, the patient lies in a left lateral position on a horizontal bed surface with the head elevated by 30°, supported by pillows to maintain a neutral spinal alignment and prevent excessive neck extension or flexion.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence of hypoxemia
Tidsram: During procedure
|
Incidence of SpO₂ ≤ 90% for >10 seconds during the examination.
|
During procedure
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Safe duration of pre-oxygenation
Tidsram: During procedure
|
Time from cessation of oxygen administration (start of anesthesia induction) to first SpO₂ <92% for ≥3 seconds.
If no desaturation occurs, the value equals the duration from oxygen cessation to end of procedure (right-censored).
|
During procedure
|
|
Incidence of subclinical respiratory depression
Tidsram: During procedure
|
Defined as the proportion of participants experiencing SpO₂ between 90% and 95% (inclusive) at any time during the examination.
|
During procedure
|
|
Requirement for jaw thrust
Tidsram: During procedure
|
Number of participants requiring manual jaw thrust to relieve airway obstruction during the examination.
|
During procedure
|
|
Requirement for nasal cannula oxygen
Tidsram: During procedure
|
Number of participants requiring oxygen supplementation via nasal cannula during the examination.
|
During procedure
|
|
Requirement for increased oxygen flow
Tidsram: During procedure
|
Number of participants requiring an increase in oxygen flow rate during the examination.
|
During procedure
|
|
Requirement for mask ventilation
Tidsram: During procedure
|
Number of participants requiring bag-mask ventilation during the examination.
|
During procedure
|
|
Requirement for endotracheal intubation
Tidsram: During procedure
|
Number of participants requiring endotracheal intubation during the examination.
|
During procedure
|
|
Incidence of airway intervention
Tidsram: During procedure
|
Proportion of participants requiring any airway intervention (jaw thrust, nasal cannula, increased flow, mask ventilation, or intubation)
|
During procedure
|
|
Severity of coughing
Tidsram: During procedure
|
Assessed using a 4-grade scale: Grade I (none), Grade II (single mild episode), Grade III (multiple episodes <15s), Grade IV (continuous >15s)
|
During procedure
|
|
Length of stay in recovery room
Tidsram: Up to 30 minutes post-anesthesia care unit (PACU) admission
|
Time from arrival to discharge from the recovery room (maximum observation 30 minutes)
|
Up to 30 minutes post-anesthesia care unit (PACU) admission
|
|
Endoscopist satisfaction score
Tidsram: During procedure
|
Assessed using a Numerical Rating Scale (NRS) ranging from 0 to 10, with higher scores indicating greater satisfaction.
|
During procedure
|
|
Incidence of postoperative nausea, vomiting, headache, and dizziness
Tidsram: Up to 30 minutes post-anesthesia care unit (PACU) admission
|
Proportion of participants experiencing nausea, vomiting, headache, or dizziness after awakening in the recovery room.
|
Up to 30 minutes post-anesthesia care unit (PACU) admission
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Safety outcome endpoints：heart rate
Tidsram: Baseline and during procedure
|
Recorded at T0 (before pre-oxygenation), T1 (before induction), T2 (scope insertion), and T3 (scope removal).
|
Baseline and during procedure
|
|
Safety outcome endpoints：blood pressure
Tidsram: Baseline and during procedure
|
Recorded at T0 (before pre-oxygenation), T1 (before induction), T2 (scope insertion), and T3 (scope removal)
|
Baseline and during procedure
|
|
Safety outcome endpoints：peripheral oxygen saturation (SpO₂)
Tidsram: Baseline and during procedure
|
Recorded at T0 (before pre-oxygenation), T1 (before induction), T2 (scope insertion), and T3 (scope removal).
|
Baseline and during procedure
|
|
Safety outcome endpoints：Incidence of hemodynamic instability in recovery
Tidsram: Up to 30 minutes post-anesthesia care unit (PACU) admission
|
Occurrence of tachycardia (>100 bpm), bradycardia (<50 bpm), or hypotension (systolic blood pressure <80 mmHg) during the recovery period.
|
Up to 30 minutes post-anesthesia care unit (PACU) admission
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Studiestol: Xinli Ni, Doctoral, General Hospital of Ningxia Medical University
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Beräknad)
23 juni 2026
Primärt slutförande (Beräknad)
31 juli 2026
Avslutad studie (Beräknad)
31 augusti 2026
Studieregistreringsdatum
Först inskickad
15 juni 2026
Först inskickad som uppfyllde QC-kriterierna
24 juni 2026
Första postat (Faktisk)
29 juni 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
29 juni 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
24 juni 2026
Senast verifierad
1 juni 2026
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- dywe0003
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .